Skip to main content

BioChek invites its customers to participate in the BioChek Ring Trial 2018 for the Infectious Bursal Disease Virus (IBD) antibody detection assay.

The Ring Trial gives BioChek customers the opportunity to check their ELISA performance by testing defined IBD-samples on the BioChek IBD antibody ELISA. Results from all participants are gathered and presented anonymously in a concise report, allowing participants to check their accuracy and precision and compare results to other BioChek users.

Participants that pass all criteria will receive a Certificate of Achievement. In case one or more criteria haven’t been met, BioChek will offer support to improve results.

The Ring Trial panel set consists of 12 vials freeze-dried serum samples, prediluted reference control CR100 (RF13) and freeze-dried reference serum CR300 (RS04).

The Ring Trial is open for all BioChek customers but do note there is only a limited number of panels available, so make sure to register as soon as possible at

BioChek customers are invited to take part in our IBD Ring Trial. You will be sent a Ring Trial Panel to be run in your lab and report the results back to BioChek. An analysis of your results and a certificate of compliance will be provided upon successful completion.The top 10 best performing labs will be published in our BioChek newsletter and on our website.

Please note:
  • We have a limited amount of Ring Trial Panels available
  • For costs of participation for this Ring Trial, please contact your local BioChek representative
  • Shipment will be together with an order, if possible. Otherwise shipping costs will be charged

Closing date for registration: March 2nd
Submission of test results: May 9th
Report & Certificate: May 21st